All companies
Visit website
SEN-JAM PHARMACEUTICAL
OperatingSen-Jam Pharmaceutical LLC
Alcohol · Founded 2017
Own a stake for health eauality; affordable and accessible for all
Valuation cap ⓘ
$80.0M
As of Apr 2024 · from SEN-JAM PHARMACEUTICAL Convertible Note 3 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$1,064,423
Across 4 rounds since 2021
Latest share price
$7.35
Sen-Jam Pharmaceutical Common Stock 2 offering price
Financials
FY2019–FY2024 · from SEC filings · hover any figure for its source$0
−$280K
2019
$0
−$337K
2020
$0
−$417K
2021
$0
−$4.0M
2022
$0
−$4.4M
2023
$0
−$4.5M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$0
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
$0
$0
Net income
-$280,006
-$336,824
-$417,348
-$3,983,709
-$4,355,706
-$4,475,577
Taxes paid
$860
$0
$0
$0
$0
$0
Balance sheet
Cash
$174
$12,255
$64,694
$181,148
$331,764
$579,282
Accounts receivable
$0
$0
$0
$0
$0
$0
Total assets
$670,364
$505,755
$560,194
$663,018
$950,081
$1,294,445
Short-term debt
$0
$15,292
$47,033
$1,992,097
$1,111,512
$2,762,742
Long-term debt
$0
$417,114
$857,159
$25,000
$1,756,115
$2,239,984
Total liabilities
$0
$432,406
$904,192
$2,017,097
$2,867,627
$5,002,726
Other
Headcount
—
4
5
5
5
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$25.0M
Valuation cap
$70.3M
post-money
$80.0M
Valuation cap
SEN-JAM PHARMACEUTICAL Convertible Note 1
Sen-Jam Pharmaceutical Common Stock 2
SEN-JAM PHARMACEUTICAL Convertible Note 3
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $3.3M
Raised — / $5MValuation cap $80M
Raised $57.2K / $4M
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 3 of 5 annual reports (FY2021–FY2025)
384 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 20 filings on EDGARSource: ManualCIK 0001802249Share price $7.35
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.